Guardant Health presented close to 30 abstracts at ASCO highlighting the technology’s myriad applications.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market PathwaysStart Trial
Automated insulin delivery systems were a highlight of this year’s (virtual) ADA meeting, with presentations on new devices from Medtronic, Tandem Diabetes Care, Insulet, Beta Bionics, and Eli Lilly, all vying for a top spot in this fast-evolving space. Industry analysts opine on their commercial prospects as well as Dexcom and Abbott’s efforts to expand CGM to the type 2 diabetes population.Subscribe now to read the full analysis